Healthcare Videos
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Healthcare Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeIndustryHealthcareVideosThe Gut–Bone Connection that Can Lower Osteoporosis Risk | Felice Gersh, MD & Mark Charbonneau, PhD
BiohackingHealthcare

The Gut–Bone Connection that Can Lower Osteoporosis Risk | Felice Gersh, MD & Mark Charbonneau, PhD

•March 2, 2026
0
Felice Gersh, MD
Felice Gersh, MD•Mar 2, 2026

Why It Matters

Understanding the gut‑bone axis enables early, non‑pharmaceutical interventions that can reduce fracture risk and open a lucrative market for microbiome‑based bone health products.

Key Takeaways

  • •Bone is living tissue constantly remodeling via osteoblasts and osteoclasts.
  • •Osteoporosis risk spikes during menopause due to estrogen decline.
  • •Gut microbiome influences bone density; germ‑free mice resist bone loss.
  • •Lifestyle factors—sleep, smoking, alcohol, stress, nutrition, exercise—modulate bone health.
  • •Early DEXA screening and targeted symbiotic supplements can prevent fractures.

Summary

Dr. Felice Gersh, an integrative OB/GYN, and Mark Charbonneau, a microbiome scientist and VP of R&D at Solaria Bio, opened the session by framing bone health as a dynamic, living process rather than a static scaffold. They highlighted osteoporosis as a progressive loss of bone mass that turns everyday falls into potentially life‑changing fractures, especially for post‑menopausal women whose estrogen drop accelerates bone resorption.

The conversation moved into the biology of bone turnover, explaining how osteoblasts build and osteoclasts break down bone tissue, and how the balance shifts with age. They underscored that osteoporosis is a continuum—osteopenia precedes full‑blown disease—and that lifestyle variables—sleep quality, smoking, alcohol intake, stress, nutrition, and resistance exercise—directly affect this balance. Crucially, they introduced emerging research linking the gut microbiome to bone density, noting that germ‑free mice do not experience menopause‑induced bone loss, suggesting microbial metabolites may modulate osteoclast activity.

Gersh described the emotional panic patients feel upon receiving a low DEXA score and outlined a “layered approach” that starts with lifestyle optimization, hormone support during perimenopause, and targeted supplementation. Charbonneau announced Solaria Bio’s new medical‑food symbiotic designed to preserve bone mass, positioning it as a non‑pharmaceutical alternative before resorting to bisphosphonates or peptide therapies. A striking quote from the talk: “If you raise mice in a bubble, they don’t lose bone,” illustrating the microbiome’s potential as a therapeutic lever.

The implications are clear: early bone density screening, combined with gut‑focused nutrition and lifestyle interventions, could shift the market from reactive osteoporosis drugs to preventive symbiotic products. Healthcare providers may adopt microbiome‑aware protocols, while biotech firms see a growth avenue in scientifically backed, gut‑bone nutraceuticals that address a sizable aging population.

Original Description

In this conversation, I’m joined by Mark Charbonneau, PhD, a scientist and microbiome researcher, to explore how bone health is influenced by hormones, inflammation, and the gut microbiome, especially during the menopause transition.
We discuss what bone really is as a living tissue, why bone loss accelerates in menopause, the difference between osteopenia and osteoporosis, and why fracture risk begins much earlier than most people realize. I also share my layered, preventive approach to bone health—starting with lifestyle, nutrition, exercise, hormone therapy, and early monitoring—long before end-stage disease develops.
Mark explains the emerging science behind the gut–bone axis, how inflammation and gut barrier dysfunction can drive bone loss, and how targeted nutritional strategies may help preserve bone mass. We also discuss new research on Bondia, a medical food designed to support bone health by addressing inflammation through the microbiome.
🎁 Discount code:
Use FELICEGERSH (case sensitive) for 20% off your first order.
At https://solaria.bio
As always, this discussion is for education only and is not a substitute for personalized medical care. Please work with your healthcare provider to determine what’s appropriate for you.
Watch for my latest Instagram lives at
https://www.instagram.com/dr.felicegersh
I am a full time practicing doctor. I see patients in my office in Irvine, CA and worldwide via telemedicine. If you need more healthcare assistance than I can provide in a video series, please contact my office:
https://integrativemgi.com/​​
#BoneHealth #OsteoporosisPrevention #MenopauseHealth #WomensHealth #PreventiveMedicine #GutMicrobiome #Healthspan #HormoneHealth
#integrativemedicine #DrFeliceGersh
----- Contents of this video ---------------------------
00:00 why bone health matters more than we realize
02:00 what bone really is and how it constantly remodels
03:45 osteoporosis vs osteopenia: understanding fracture risk
06:30 why bone loss accelerates during menopause
09:30 the role of hormones in bone remodeling
12:00 lifestyle medicine for bone health: sleep, nutrition, exercise
14:00 introducing the gut–bone connection
16:30 how inflammation and gut barrier dysfunction affect bones
20:30 microbiome science and preserving bone mass
26:30 a layered, preventive approach to lifelong bone health
0

Comments

Want to join the conversation?

Loading comments...